Danish pharmaceutical company Novo Nordisk has launched “My$99Insulin Program” in order to help diabetic patients to afford insulin. The program involves online enrollment on novocare.com, which includes approved generic versions of insulin manufactured by the company, along with an “Immediate Supply” option.
Related Articles
The post Novo Nordisk Launches “My$99Insulin Program” appeared first on Latest Health & Medical News – Myhealthyclick.com.